Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy
GARCIA-CARBONERO, R, SUPKO, J. G, MATULONIS, U, MAKI, R. G, LOPEZ, T, PUCHALSKI, T. A, SANCHO, M. A, GOMEZ, J, GUZMAN, C, JIMENO, J, DEMETRI, G. D, MANOLA, J, SEIDEN, M. V, HARMON, D, RYAN, D. P, QUIGLEY, M. T, MERRIAM, P, CANNIFF, J, GOSS, G
Published in Journal of clinical oncology (15.04.2004)
Published in Journal of clinical oncology (15.04.2004)
Get full text
Journal Article
Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study
GARCIA-CARBONERO, R, SUPKO, J. G, QUIGLEY, M. T, LOPEZ, T, SANCHO, M. A, JIMENO, J, GUZMAN, C, DEMETRI, G. D, MAKI, R. G, MANOLA, J, RYAN, D. P, HARMON, D, PUCHALSKI, T. A, GOSS, G, SEIDEN, M. V, WAXMAN, A
Published in Journal of clinical oncology (20.08.2005)
Published in Journal of clinical oncology (20.08.2005)
Get full text
Journal Article
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
Klein, E.A., Richards, D., Cohn, A., Tummala, M., Lapham, R., Cosgrove, D., Chung, G., Clement, J., Gao, J., Hunkapiller, N., Jamshidi, A., Kurtzman, K.N., Seiden, M.V., Swanton, C., Liu, M.C.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype
Duan, Z, Lamendola, D E, Yusuf, R Z, Penson, R T, Preffer, F I, Seiden, M V
Published in Anticancer research (01.07.2002)
Get more information
Published in Anticancer research (01.07.2002)
Journal Article
Discovery of Differentially Expressed Genes Associated with Paclitaxel Resistance Using cDNA Array Technology: Analysis of Interleukin (IL) 6, IL-8, and Monocyte Chemotactic Protein 1 in the Paclitaxel-resistant Phenotype
Duan, Z, Feller, A J, Penson, R T, Chabner, B A, Seiden, M V
Published in Clinical cancer research (01.11.1999)
Get full text
Published in Clinical cancer research (01.11.1999)
Journal Article
Predictors of skeletal complications in patients with metastatic breast carcinoma
Domchek, Susan M., Younger, Jerry, Finkelstein, Dianne M., Seiden, Michael V.
Published in Cancer (15.07.2000)
Published in Cancer (15.07.2000)
Get full text
Journal Article
Detection of circulating tumor cells in men with localized prostate cancer
Seiden, M V, Kantoff, P W, Krithivas, K, Propert, K, Bryant, M, Haltom, E, Gaynes, L, Kaplan, I, Bubley, G, DeWolf, W
Published in Journal of clinical oncology (01.12.1994)
Published in Journal of clinical oncology (01.12.1994)
Get more information
Journal Article
Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer
Brakora, K.A, Lee, H, Yusuf, R, Sullivan, L, Harris, A, Colella, T, Seiden, M.V
Published in Gynecologic oncology (01.05.2004)
Published in Gynecologic oncology (01.05.2004)
Get full text
Journal Article
Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation
Yusuf, R Z, Duan, Z, Lamendola, D E, Penson, R T, Seiden, M V
Published in Current cancer drug targets (01.02.2003)
Published in Current cancer drug targets (01.02.2003)
Get more information
Journal Article
A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies
Matulonis, U, Campos, S, Duska, L, Fuller, A, Berkowitz, R, Gore, S, Roche, M, Colella, T, Lee, H, Seiden, M.V
Published in Gynecologic oncology (01.11.2003)
Published in Gynecologic oncology (01.11.2003)
Get full text
Journal Article
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours
PENSON, R. T, SEIDEN, M. V, MATULONIS, U. A, APPLEMAN, L. J, FULLER, A. F, GOODMAN, A, CAMPOS, S. M, CLARK, J. W, ROCHE, M, EDER, J. P
Published in British journal of cancer (11.07.2005)
Published in British journal of cancer (11.07.2005)
Get full text
Journal Article
A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies
Seiden, M.V, Burris, H.A, Matulonis, U, Hall, J.B, Armstrong, D.K, Speyer, J, Weber, J.D.A, Muggia, F
Published in Gynecologic oncology (01.03.2007)
Published in Gynecologic oncology (01.03.2007)
Get full text
Journal Article
Attitudes to chemotherapy in patients with ovarian cancer
Penson, R.T., Dignan, F., Seiden, M.V., Lee, H., Gallagher, C.J., Matulonis, U.A., Olson, K., Gibbens, I., Gore, M.E.
Published in Gynecologic oncology (01.08.2004)
Published in Gynecologic oncology (01.08.2004)
Get full text
Journal Article
Biologic Activity of Cytotoxic T Lymphocyte-Associated Antigen 4 Antibody Blockade in Previously Vaccinated Metastatic Melanoma and Ovarian Carcinoma Patients
Hodi, F. Stephen, Mihm, Martin C., Soiffer, Robert J., Haluska, Frank G., Butler, Marcus, Seiden, Michael V., Davis, Thomas, Henry-Spires, Rochele, MacRae, Suzanne, Willman, Ann, Padera, Robert, Jaklitsch, Michael T., Shankar, Sridhar, Chen, Teresa C., Korman, Alan, Allison, James P., Dranoff, Glenn
Published in Proceedings of the National Academy of Sciences - PNAS (15.04.2003)
Published in Proceedings of the National Academy of Sciences - PNAS (15.04.2003)
Get full text
Journal Article
Adaptation of solid phase extraction to an automated column switching method for online sample cleanup as the basis of a facile and sensitive high-performance liquid chromatographic assay for paclitaxel in human plasma
Supko, J.G, Nair, R.V, Seiden, M.V, Lu, H
Published in Journal of pharmaceutical and biomedical analysis (01.12.1999)
Published in Journal of pharmaceutical and biomedical analysis (01.12.1999)
Get full text
Journal Article
TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma
Feller, A J, Duan, Z, Penson, R, Toh, H C, Seiden, M V
Published in Anticancer research (01.11.2000)
Get more information
Published in Anticancer research (01.11.2000)
Journal Article
Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer
VASEY, P. A, SHULMAN, L. N, KAYE, S. B, CAMPOS, S, DAVIS, J, GORE, M, JOHNSTON, S, KIRN, D. H, O'NEILL, V, SIDDIQUI, N, SEIDEN, M. V
Published in Journal of clinical oncology (15.03.2002)
Published in Journal of clinical oncology (15.03.2002)
Get full text
Journal Article
A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors
PENSON, R.T., CAMPOS, S.M., SEIDEN, M.V., KRASNER, C., FULLER, A.F., GOODMAN, A., ROCHE, M., WILLMAN, A., MUZIKANSKY, A., MATULONIS, U.A.
Published in International journal of gynecological cancer (01.11.2005)
Published in International journal of gynecological cancer (01.11.2005)
Get full text
Journal Article